title: Persistent hiccups as an adverse event to FLAG-IDA regimen for leukemia.
authors.affiliation: Department of Oncology, Hematology and Respiratory Diseases, University of Modena and Reggio Emilia, Azienda Ospedaliera Policlinico, Modena, Italy.
authors.forename: Fabio
authors.initials: F
authors.lastname: Forghieri
authors.forename: Monica
authors.initials: M
authors.lastname: Maccaferri
authors.forename: Monica
authors.initials: M
authors.lastname: Morselli
authors.forename: Leonardo
authors.initials: L
authors.lastname: Potenza
authors.forename: Francesco
authors.initials: F
authors.lastname: Volzone
authors.forename: Elena
authors.initials: E
authors.lastname: Bandieri
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Torelli
authors.forename: Mario
authors.initials: M
authors.lastname: Luppi
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D003561:Cytarabine / Q000009:adverse effects; D000069585:Filgrastim; D016179:Granulocyte Colony-Stimulating Factor / Q000009:adverse effects; D006606:Hiccup / Q000139:chemically induced* / Q000188:drug therapy; D006801:Humans; D015255:Idarubicin / Q000009:adverse effects; D004915:Leukemia, Erythroblastic, Acute / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012074:Remission Induction; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D011994:Recombinant Proteins; D003561:Cytarabine; D016179:Granulocyte Colony-Stimulating Factor; D014740:Vidarabine; D000069585:Filgrastim; D015255:Idarubicin